Metaboost Rx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.5/10
Best for: flat-rate GLP-1 intro pricing plus a lower-dose microdose track
Metaboost Rx scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
then $199/mo ongoing
Tirzepatide
then $249/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Metaboost Rx is an Oklahoma City-based telehealth practice offering physician-directed compounded GLP-1 programs. Semaglutide is advertised at $129/mo and tirzepatide at $149/mo as a new-patient offer against regular prices of $199 and $249, plus a lower-dose GLP-1 Microdose track at $199/mo. Plans bill every 30 days with a 'no dose-change surcharges' promise, and you aren't charged if a provider doesn't approve you.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Metaboost Rx
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
from $199/mo (after intro offer) · no insurance needed
Metaboost Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (after intro offer) ($129 intro price)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Metaboost Rx
Each dimension is scored algorithmically from Metaboost Rx’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.3/10At $199/mo (after intro offer), Metaboost Rx runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $129. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.2/10Metaboost Rx offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.9/10Online intake and platform experience (app/portal-based, consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.1/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.
Accessibility10%
5.2/10Metaboost Rx's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.0/10Metaboost Rx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Metaboost Rx review
Last checked October 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$249/mo across 3 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Metaboost Rx
We walked Metaboost Rx’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1'Check My Eligibility' on the homepage opens an intake headed 'See if GLP-1 is right for you.'
- 2First screen asks 'What would you like support with?' with four goal choices (long-term health, feel better day to day, confidence and appearance, reduce health risks)
- 3Next screen asks 'How active are you usually?' (very, moderately, or not very active); we stopped here because the questions turn to lifestyle and health details
- Prices are on the homepage before the quiz: semaglutide 'from $129/mo' (with $199 crossed out) and tirzepatide 'from $149/mo' (with $249 crossed out), labeled a new patient offer
- The individual treatment pages no longer show any price, so you have to go back to the homepage to see what a plan costs
- The Terms say plans are charged 'immediately and every 30 days thereafter' and that you get a notice 5 to 7 days before each charge
- Marketing repeats '$0 if not approved,' and the Terms confirm a refund if the provider declines to prescribe
- We did not enter any personal or health information, create an account, or pay
Metaboost Rx customer support
- Phone
- (405) 914-4797
- Hours
- Monday-Friday 9:00 AM - 5:00 PM
GLP-1 medications Metaboost Rx offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Shown as $129/mo with $199 struck through under a 'New patient offer' banner; the site doesn't say how long $129 lasts. Flat rate, 'no dose-change surcharges'
Shown as $149/mo with $249 struck through under a 'New patient offer' banner; the site doesn't say how long $149 lasts. Flat rate, 'no dose-change surcharges'
$199/mo with no struck-through price; the microdose page doesn't name the molecule (recorded as semaglutide from the earlier review)
Ready to get started?
Plans and promotions change often, so check Metaboost Rx's current pricing and active discounts before you decide.
What we like
- Named legal entity (Metaboost-Rx LLC) with real Terms, Privacy, and HIPAA Notice pages, not just boilerplate
- Intro pricing of $129/mo semaglutide and $149/mo tirzepatide, with a 'no dose-change surcharges' promise
- Pay-after-approval funnel: you aren't charged if a provider declines, and the Terms confirm a refund in that case
- Adds a distinct lower-dose GLP-1 Microdose track ($199/mo) for patients who want metabolic benefits without aggressive weight loss
- Prices are shown on the homepage before you start the eligibility quiz
Watch-outs
- The $129 and $149 prices are a 'new patient offer' against $199 and $249 regular prices, and the site doesn't say when the offer ends
- Displays a 'Rated Excellent 4.8/5' Trustpilot badge, but we couldn't find a Trustpilot profile for the business
- State availability is inconsistent: one FAQ says 'all 50 states,' another says only 'the states where we operate,' with no list
- Contact is a Gmail address (metaboostrx@gmail.com) and the listed address is a suite/mailbox-style unit, not a standalone clinic
- Cancellation rules conflict: the Terms allow canceling up to 48 hours before billing, but program FAQs require 30 days' notice
- No named compounding pharmacy partner and no LegitScript or PCAB accreditation shown anywhere on the site
- A new 'GLP-1 Oral' option ($229/mo) doesn't say which medication it contains
Is Metaboost Rx worth it?
Metaboost Rx's whole pitch comes down to this: flat-rate GLP-1 intro pricing plus a lower-dose microdose track. New patients start at $129/month as an intro price, but the price steps up to $199/month (after intro offer) after the intro period, so treat the headline number as an intro offer, not the standing rate. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.
On top of the core program, it charges the same price at every dose and doesn't charge you until you're approved.
How much Metaboost Rx costs
- Compounded semaglutide is currently $129/month on an intro offer, regularly $199/month, for that option.
- Compounded tirzepatide is currently $149/month on an intro offer, regularly $249/month, if you go that route.
Because Metaboost Rx's headline figure is a after intro offer, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Metaboost Rx with the month-to-month prices of the alternatives below instead.
Belle Health (about $199/month) is one of the closest alternatives to weigh Metaboost Rx against.
Medications: what Metaboost Rx prescribes
Metaboost Rx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Metaboost Rx is best for, and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Metaboost Rx dispenses through an accredited compounding pharmacy, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Metaboost Rx is one of the easiest ways to start a GLP-1 cheaply, as long as you go in knowing that the $129 intro price steps up to $199/month (after intro offer) after the intro period. Use that window to confirm the medication works for you, then re-check the ongoing math before you settle in.
The Bottom Line
Metaboost Rx scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Metaboost Rx?
From $199/mo (after intro offer). See current pricing and start your free consultation.
Metaboost Rx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Metaboost Rx vs…
Metaboost Rx scores6.5/10
Side-by-side pricing, medications and scores. Pick a matchup.
Metaboost Rx vs Amazon One Medical
Amazon One Medical scores 8.5/10
Metaboost Rx vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Metaboost Rx review:
Sources & methodology (as of October 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Metaboost Rx's current pricing
Plans from $199/mo (after intro offer). Start your free consultation to check eligibility and today's price.